WallStSmart

GE HealthCare Technologies Inc. (GEHC)vsInfuSystems Holdings Inc (INFU)

VS
⚡

Smart Verdict

WallStSmart Research — data-driven comparison

GE HealthCare Technologies Inc. generates 14995% more annual revenue ($21.64B vs $143.34M). GEHC leads profitability with a 9.9% profit margin vs 6.0%. INFU appears more attractively valued with a PEG of 1.73. GEHC earns a higher WallStSmart Score of 66/100 (B-).

GEHC

Strong Buy

66

out of 100

Grade: B-

Growth: 6.7Profit: 7.0Value: 5.7Quality: 4.5
Piotroski: 2/9Altman Z: 1.34

INFU

Buy

56

out of 100

Grade: C

Growth: 6.0Profit: 5.5Value: 5.3Quality: 7.5
Piotroski: 6/9Altman Z: 1.96
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

Intrinsic value data unavailable for GEHC.

INFUUndervalued (+27.7%)

Margin of Safety

+27.7%

Fair Value

$10.53

Current Price

$14.79

$4.26 discount

UndervaluedFair: $10.53Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

GEHC2 strengths · Avg: 8.0/10
P/E RatioValuation
17.7x8/10

Attractively priced relative to earnings

EPS GrowthGrowth
39.0%8/10

Earnings expanding 39.0% YoY

INFU1 strengths · Avg: 8.0/10
EPS GrowthGrowth
25.0%8/10

Earnings expanding 25.0% YoY

Areas to Watch

GEHC3 concerns · Avg: 3.0/10
PEG RatioValuation
2.254/10

Expensive relative to growth rate

Piotroski F-ScoreQuality
2/93/10

Weak financial health signals

Altman Z-ScoreHealth
1.342/10

Distress zone — elevated risk

INFU4 concerns · Avg: 4.0/10
PEG RatioValuation
1.734/10

Expensive relative to growth rate

P/E RatioValuation
32.9x4/10

Premium valuation, high expectations priced in

Revenue GrowthGrowth
2.6%4/10

2.6% revenue growth

Altman Z-ScoreHealth
1.964/10

Grey zone — moderate risk

Comparative Analysis Report

WallStSmart Research

Bull Case : GEHC

The strongest argument for GEHC centers on P/E Ratio, EPS Growth.

Bull Case : INFU

The strongest argument for INFU centers on EPS Growth.

Bear Case : GEHC

The primary concerns for GEHC are PEG Ratio, Piotroski F-Score, Altman Z-Score.

Bear Case : INFU

The primary concerns for INFU are PEG Ratio, P/E Ratio, Revenue Growth.

Key Dynamics to Monitor

INFU carries more volatility with a beta of 1.38 — expect wider price swings.

GEHC is growing revenue faster at 7.2% — sustainability is the question.

GEHC generates stronger free cash flow (793M), providing more financial flexibility.

Monitor MEDICAL DEVICES industry trends, competitive dynamics, and regulatory changes.

Bottom Line

GEHC scores higher overall (66/100 vs 56/100). INFU offers better value entry with a 27.7% margin of safety. Both earn "Strong Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

GE HealthCare Technologies Inc.

HEALTHCARE · MEDICAL DEVICES · USA

GE HealthCare Technologies Inc. provides medical technology, pharmaceutical diagnostics, and digital solutions in the United States. The company is headquartered in Chicago, Illinois.

InfuSystems Holdings Inc

HEALTHCARE · MEDICAL DEVICES · USA

InfuSystem Holdings, Inc., provides infusion pumps and related products and services in the United States and Canada. The company is headquartered in Rochester Hills, Michigan.

Want to dig deeper into these stocks?